Updated: June 10, 2021 06:19 PM
Created: June 10, 2021 03:46 PM
(ABC 6 News) - A new Mayo Clinic study shows monoclonal antibodies are a safe COVID-19 treatment for transplant patients.
Transplant patients have a higher risk of severe illness and death if they catch COVID-19.
Monoclonal antibody therapy is really important for the transplant population because they are less likely to develop immunity. Providing them with these antibodies helps them recover from COVID-19.
Monoclonal antibodies help prevent the virus that causes COVID-19 from attaching to human cells, which helps block the spread of infection.
Experts at Mayo say it's important for transplant patients to know about this treatment as early as possible.
"It affords protection for them because transplant patients have impaired ability to develop an immune response to infections such as COVID as well as the vaccinations so this is another mechanism that we can use to help prevent them from getting a severe illness," says Dr. Raymund Razonable, Professor of Medicine, Mayo Clinic.
Knowing how to treat transplant patients is crucial, especially given that recent studies show COVID-19 vaccines are not as effective for transplant patients.
Copyright 2021 - KAAL-TV, LLC A Hubbard Broadcasting Company